Analysis of the BCR-ABL protein in Philadelphia chromosome positive adult acute lymphocytic leukemia (ALL) by enhanced chemiluminiscence western blotting (Eq-WB).

被引：0
|
作者：
Bseiso, AW
Kantarjian, HM
Guo, JQ
Talpaz, M
OBrien, S
Koller, C
Albitar, M
Keating, M
Arlinghaus, R
机构：
[1] UNIV TEXAS,MD ANDERSON CANCER CTR,SECT HEMATOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANCER CTR,SECT MOL PATHOL,HOUSTON,TX 77030
[3] UNIV TEXAS,MD ANDERSON CANCER CTR,SECT BIOIMMUNOTHERAPY,HOUSTON,TX 77030
[4] UNIV TEXAS,MD ANDERSON CANCER CTR,LAB MED,HOUSTON,TX 77030
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3335 / 3335
页数：1
相关论文
共 50 条
  • [11] EXPRESSION OF A DISTINCTIVE BCR-ABL ONCOGENE IN PH1-POSITIVE ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
    CLARK, SS
    MCLAUGHLIN, J
    TIMMONS, M
    PENDERGAST, AM
    BEN-NERIAH, Y
    DOW, LW
    CRIST, W
    ROVERA, G
    SMITH, SD
    WITTE, ON
    SCIENCE, 1988, 239 (4841) : 775 - 777
  • [12] The development of agents targeting the BCR-ABL tyrosine kinase as Philadelphia chromosome-positive acute lymphoblastic leukemia treatment
    Thomas, Xavier
    Heiblig, Mael
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (11) : 1061 - 1070
  • [13] The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement
    L Pajor
    JA Vass
    L Kereskai
    P Kajtár
    Á Szomor
    M Egyed
    J Iványi
    P Jáksó
    Leukemia, 2000, 14 : 1122 - 1126
  • [14] The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement
    Pajor, L
    Vass, JA
    Kereskai, L
    Kajtár, P
    Szomor, A
    Egyed, M
    Iványi, J
    Jáksó, P
    LEUKEMIA, 2000, 14 (06) : 1122 - 1126
  • [15] Mechanisms of BCR-ABL leukemogenesis and novel targets for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
    Platanias, Leonidas C.
    LEUKEMIA & LYMPHOMA, 2011, 52 : 2 - 3
  • [16] Serial monitoring of BCR-ABL in newly diagnosed Philadelphia chromosome-positive (Ph plus ) acute lymphoblastic leukemia (ALL) treated with imatinib.
    Lim, Sung-Nam
    Joo, Young-Don
    Kim, Ii-Hwan
    Lee, Won-Sik
    Lee, Sang Min
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [17] IMMUNOLOGICAL CHARACTERIZATION OF THE TUMOR-SPECIFIC BCR-ABL JUNCTION IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
    VANDENDEREN, J
    VANDERPLAS, D
    MEEUWSEN, T
    ZEGERS, N
    BOERSMA, W
    GROSVELD, G
    VANEWIJK, W
    BLOOD, 1990, 76 (01) : 136 - 141
  • [18] A NOVEL 203 KD ABERRANT BCR-ABL PRODUCT IN A GIRL WITH PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
    INUKAI, T
    SUGITA, K
    SUZUKI, T
    IJIMA, K
    GOI, K
    TEZUKA, T
    KOJIKA, S
    HATAKEYAMA, K
    KAGAMI, K
    MORI, T
    OKAZAKI, T
    MIZUTANI, S
    NAKAZAWA, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 85 (04) : 823 - 825
  • [19] POLYMERASE CHAIN-REACTION ANALYSIS OF BCR-ABL SEQUENCES IN ADULT PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS
    JANSSEN, JWG
    FONATSCH, C
    LUDWIG, WD
    RIEDER, H
    MAURER, J
    BARTRAM, CR
    LEUKEMIA, 1992, 6 (05) : 463 - 464
  • [20] Clinical characteristics and outcomes of adults with Philadelphia chromosome positive and/or bcr-abl positive acute lymphoblastic leukemia: a single center study from China
    Li, Yenan
    Zou, Dehui
    Zhao, Yaozhong
    Mi, Yingchang
    Wang, Jianxiang
    Qiu, Lugui
    LEUKEMIA & LYMPHOMA, 2010, 51 (03) : 488 - 496
12345